Patients with severe asthma are now able to choose where they receive treatment - at home or via a healthcare professional.
Wheezo will become an absolute necessity for home monitoring of severe asthma if patients choose to self administer.
And the data/info wheezo is capturing will be most important to physicians and better understand how patients are monitoring their asthma.
https://www.healthindustryhub.com.au/pharmaceutical-news-trends/gsks-targeted-therapy-for-asthma-gains-pbs-listing-for-self-administration-delivery/
Cheers
